Out of all possible locations in the United States, German seed company KWS chose St. Louis as the site of its North American headquarters. What made St. Louis stand out from the rest?
According to Donald Danforth Plant Science Center President James Carrington and COO Sam Fiorello, KWS was attracted to the St. Louis region because of its community spirit and because of the world-class research facilities available at the Bio-Research & Development Growth Park (BRDG Park) on the Danforth Center campus.
Brian Gass is a bit different than many of the people he encounters hiking the Pacific Crest Trail. He spends a lot more time concerned with his skin. Gass has ichthyosis, a rare genetic skin disease that manifests itself as thickening or thinning of the skin, sometimes giving a scaly appearance or becoming very dry, flaky and itchy. For Gass, it requires copious amounts of lotion, long-sleeves, and frequent night-hiking to avoid the sun. Gass talked to St. Louis on the Air host Don Marsh earlier this week from Lake Tahoe.
At the end of May, the "For the Sake of All" research team published its final report on the health and well-being of African Americans in the St. Louis region, a multi-disciplinary study led by Jason Purnell, an assistant professor with the Brown School of Social Work at Washington University in St. Louis.
Missouri's Conservation Commission voted unanimously Friday to adopt a list of recommendations designed to prevent the spread of Chronic Wasting Disease, or CWD, from captive white tail deer to the wild population.
The recommendations primarily target privately owned fields, pens and reserves where trophy deer are raised to be hunted. Mike Hubbard, chief of the Department of Conservation's (MDC) Resource Science Division, says the recommendations include banning the import of white tail deer, mule deer and their hybrids into Missouri.
Dr. Bradley Schlaggar and his colleagues at the Washington University School of Medicine used magnetic resonance imaging (MRI) to visualize "chemobrain," a phenomenon that many patients receiving chemotherapy describe as a "mental fog."
Most people have heard about the undesirable side effects that chemotherapy has on the body of people suffering from cancer. There's balding, fatigue and loss of appetite, to name a few.
Until recently, however, chemotherapy’s effects on the brain weren’t widely recognized. The cognitive side effects – a fuzzy memory and poor attention span – were usually dismissed by physicians, scientists and even some cancer patients.
The symptoms have a name: Post-chemotherapy cognitive impairment, or “chemobrain,” among those who suffer from it.